Thursday, April 18th | 11:30am - 12:00pm ET
The 340B drug pricing program is entering an exciting phase of evolution. The SUSTAIN 340B Act and the 340B Patients Act demonstrate a strong commitment to refining the program, ensuring it serves patients effectively while maintaining accountability. This active legislative engagement, alongside legal discussions and state-level initiatives, signals a healthy process of improvement. Covered entities (CEs) now have a unique opportunity to collaborate with policymakers and shape the 340B program to best serve those in need.
This webinar will help you understand the potential changes, and equip you to advocate for your interests.
Here's what we'll cover:
• Manufacturer Restrictions: Analyze recent limitations and their potential impact on CEs.
• Understanding Key Legislation: Compare and contrast the SUSTAIN 340B Act and the 340B Patients Act.
• Examining the Arkansas Victory: Learn how this legal win could affect challenges to manufacturer restrictions.
• Tracking State-Level Legislation: Discover which states support or oppose contract pharmacy networks.
Who should attend:
• Covered entities in the 340B program
• Finance Directors
• Program Managers
• Pharmacy Directors
• HR Managers/Directors
• Anyone interested in learning more about the 340B program
With an unsurpassed reputation in delivering 340B administration, PharmaForce is the only Pharmacy Solutions Provider composed entirely of experienced industry professionals, developing uniquely flexible technology solutions for pharmacies, providers and patients demanding greater transparency and lower costs.
This post is related to:
Distribution: 340B Solutions, 340B Management Systems
